Page last updated: 2024-09-03

imatinib mesylate and Animal Mammary Carcinoma

imatinib mesylate has been researched along with Animal Mammary Carcinoma in 2 studies

Research

Studies (2)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	1 (50.00)	29.6817
2010's	1 (50.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Allington, TM; Galliher-Beckley, AJ; Schiemann, WP	1
Constance, JE; Lim, CS; Matissek, KJ; Mossalam, M; Woessner, DW	1

Other Studies

2 other study(ies) available for imatinib mesylate and Animal Mammary Carcinoma

Article	Year
Activated Abl kinase inhibits oncogenic transforming growth factor-beta signaling and tumorigenesis in mammary tumors. FASEB journal : official publication of the Federation of American Societies for Experimental Biology, 2009, Volume: 23, Issue:12 Topics: Animals; Benzamides; Cell Line, Tumor; Epithelial Cells; Female; Imatinib Mesylate; Mammary Glands, Animal; Mammary Neoplasms, Animal; Metalloproteases; Mice; Mice, Inbred BALB C; Piperazines; Protein Kinase Inhibitors; Pyrimidines; Signal Transduction; Transforming Growth Factor beta	2009
Enhanced and selective killing of chronic myelogenous leukemia cells with an engineered BCR-ABL binding protein and imatinib. Molecular pharmaceutics, 2012, Nov-05, Volume: 9, Issue:11 Topics: Animals; Annexin A5; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Apoptosis; Benzamides; Blotting, Western; Cell Proliferation; Cells, Cultured; Chlorocebus aethiops; COS Cells; Drug Synergism; Female; Fibroblasts; Flow Cytometry; Fusion Proteins, bcr-abl; Green Fluorescent Proteins; Humans; Imatinib Mesylate; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Mammary Neoplasms, Animal; Mice; Mitochondria; Oxidative Stress; Phosphorylation; Piperazines; Pyrimidines	2012

Article

Year

Activated Abl kinase inhibits oncogenic transforming growth factor-beta signaling and tumorigenesis in mammary tumors.

FASEB journal : official publication of the Federation of American Societies for Experimental Biology, 2009, Volume: 23, Issue:12

Topics: Animals; Benzamides; Cell Line, Tumor; Epithelial Cells; Female; Imatinib Mesylate; Mammary Glands, Animal; Mammary Neoplasms, Animal; Metalloproteases; Mice; Mice, Inbred BALB C; Piperazines; Protein Kinase Inhibitors; Pyrimidines; Signal Transduction; Transforming Growth Factor beta

2009

Enhanced and selective killing of chronic myelogenous leukemia cells with an engineered BCR-ABL binding protein and imatinib.

Molecular pharmaceutics, 2012, Nov-05, Volume: 9, Issue:11

Topics: Animals; Annexin A5; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Apoptosis; Benzamides; Blotting, Western; Cell Proliferation; Cells, Cultured; Chlorocebus aethiops; COS Cells; Drug Synergism; Female; Fibroblasts; Flow Cytometry; Fusion Proteins, bcr-abl; Green Fluorescent Proteins; Humans; Imatinib Mesylate; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Mammary Neoplasms, Animal; Mice; Mitochondria; Oxidative Stress; Phosphorylation; Piperazines; Pyrimidines

2012